IL315686A - Crystalline forms of macrocyclic peptide antibiotics - Google Patents
Crystalline forms of macrocyclic peptide antibioticsInfo
- Publication number
- IL315686A IL315686A IL315686A IL31568624A IL315686A IL 315686 A IL315686 A IL 315686A IL 315686 A IL315686 A IL 315686A IL 31568624 A IL31568624 A IL 31568624A IL 315686 A IL315686 A IL 315686A
- Authority
- IL
- Israel
- Prior art keywords
- crystalline forms
- macrocyclic peptide
- peptide antibiotic
- antibiotic
- macrocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22167057 | 2022-04-07 | ||
| PCT/EP2023/058906 WO2023194418A1 (en) | 2022-04-07 | 2023-04-05 | Crystalline forms of a macrocyclic peptide antibiotic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL315686A true IL315686A (en) | 2024-11-01 |
Family
ID=81448543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL315686A IL315686A (en) | 2022-04-07 | 2023-04-05 | Crystalline forms of macrocyclic peptide antibiotics |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4504749A1 (enExample) |
| JP (1) | JP2025511869A (enExample) |
| KR (1) | KR20240169690A (enExample) |
| CN (1) | CN118974073A (enExample) |
| AU (1) | AU2023250008A1 (enExample) |
| CA (1) | CA3255726A1 (enExample) |
| IL (1) | IL315686A (enExample) |
| MX (1) | MX2024012228A (enExample) |
| TW (1) | TW202404991A (enExample) |
| WO (1) | WO2023194418A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026154152A1 (en) * | 2025-01-20 | 2026-07-23 | F. Hoffmann-La Roche Ag | Pharmaceutical compositions comprising an antibiotic macrocyclic peptide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11819532B2 (en) | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
-
2023
- 2023-04-05 WO PCT/EP2023/058906 patent/WO2023194418A1/en not_active Ceased
- 2023-04-05 JP JP2024559427A patent/JP2025511869A/ja active Pending
- 2023-04-05 KR KR1020247036516A patent/KR20240169690A/ko active Pending
- 2023-04-05 CN CN202380032881.2A patent/CN118974073A/zh active Pending
- 2023-04-05 CA CA3255726A patent/CA3255726A1/en active Pending
- 2023-04-05 AU AU2023250008A patent/AU2023250008A1/en active Pending
- 2023-04-05 EP EP23718634.1A patent/EP4504749A1/en active Pending
- 2023-04-05 IL IL315686A patent/IL315686A/en unknown
- 2023-04-06 TW TW112112829A patent/TW202404991A/zh unknown
-
2024
- 2024-10-03 MX MX2024012228A patent/MX2024012228A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN118974073A (zh) | 2024-11-15 |
| CA3255726A1 (en) | 2023-10-12 |
| EP4504749A1 (en) | 2025-02-12 |
| MX2024012228A (es) | 2024-11-08 |
| WO2023194418A1 (en) | 2023-10-12 |
| TW202404991A (zh) | 2024-02-01 |
| KR20240169690A (ko) | 2024-12-03 |
| AU2023250008A1 (en) | 2024-10-03 |
| JP2025511869A (ja) | 2025-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL317277A (en) | Process for producing a macrocyclic antibiotic peptide | |
| IL316075A (en) | Crystalline form of lenifranor | |
| AU2023410324A1 (en) | Crystalline forms of a her2 inhibitor | |
| IL321665A (en) | Crystalline forms of LPA1 antagonist | |
| IL321171A (en) | Crystalline forms of 2-oxoquinazoline | |
| GB202005114D0 (en) | Crystalline Forms of a Pharmaceutical Compound | |
| IL304683A (en) | Crystalline form of a piperazinyl-thiazole derivative | |
| CA3262067A1 (en) | Process for manufacturing an antibiotic macrocyclic peptide | |
| EP4121434A4 (en) | CRYSTALLINE FORMS OF SQUALAMINE | |
| GB202511112D0 (en) | Antibiotic combinations | |
| GB202207185D0 (en) | Novel antibiotic compound | |
| GB202510327D0 (en) | Crystalline forms of a compound | |
| HK40128931A (en) | A novel crystalline form of pritelivir | |
| HK40127638A (en) | A novel crystalline form of pritelivir | |
| HK40106413A (en) | Crystalline forms of isoxazoline compound | |
| CA3227010A1 (en) | Crystalline forms of ozanimod hydrochloride | |
| HK40086278A (en) | Crystalline forms of a tyk2 inhibitor | |
| CA3283566A1 (en) | Crystalline form of midazolam hydrochloride | |
| AU2024361448A1 (en) | Crystalline forms of mrtx0902 | |
| CA3288524A1 (en) | Crystalline forms of evenamide | |
| HRP20260447T1 (hr) | Kristalni oblici evenamida | |
| HK40115309A (en) | Sequential deposition of perovskites | |
| CA3277808A1 (en) | Crystalline forms of a lpa1 antagonist | |
| HK40116601A (en) | Crystalline form of lanifibranor | |
| CA3281786A1 (en) | Timing related status update |